Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 32Unknown 2Withdrawn 1Terminated 1Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 23OTHER_GOV 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 4Non-Muscle Invasive Bladder Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Sarcoma, Kaposi 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Melanoma 2Lymphoma 2Colorectal Neoplasms 2Clear-cell metastatic renal cell carcinoma 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Neoplasms 1Musculoskeletal Pain 1Multiple Myeloma 1Malignant Solid Neoplasm 1

Interventions

Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Kidney Neoplasms × Clear all
NCT06783348 2025-01-23

RENALUT

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Not yet recruiting
48 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡